Earlier this month, a federal jury awarded $15 million in compensatory damages to a 10-year-old boy whose mother alleged her son suffered a Depakote birth defect.
She was on AbbVie Inc.’s bipolar drug Depakote while she was pregnant.
The boy was born with spina bifida, a condition his mother alleged resulted from her taking Depakote to treat bipolar disorder while she was pregnant, claiming she was not adequately warned about the risk of birth defects associated with the medication.
The lawsuit also made allegations that the drug was defectively designed and inadequately tested.
Depakote, an anticonvulsant, and mood stabilizing medication, is used to treat several conditions, including epilepsy, bipolar disorder, migraine headaches, mania, and behavioral problems associated with Alzheimer’s disease or dementia.
The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study published in the August 2006 issue of Neurology found that approximately 20.3 percent of pregnant women who took Depakote suffered serious adverse side effects related to their birth of their offspring, as compared to only one to 10.7 percent with other similar medications.
In response to this study, the U.S. Food and Drug Administration (FDA) issued a Black Box warning several months later.
According to the FDA, the use of Depakote by pregnant women can produce teratogenic effects at birth children resulting in congenital malformations such as spina bifida, brain defects, and malformations of the face, skull or cardiovascular system.
Depakote is also known to cause decreased IQ scores in children.
In addition, Depakote has also been linked to valproate syndrome, a rare condition that can cause children to develop facial deformities that may take time to evolve.
For this reason, the FDA warns that women of childbearing age must weigh the risk of taking Depakote against these known side effects in their offspring.
Mothers who believe a drug they took during pregnancy could have caused a birth defect continue to file lawsuits against Abbvie, the maker of Depakote.
According to Abbvie, approximately 695 injury claims are currently pending and Depakote lawyers continue to speak with families who believe they may qualify for a lawsuit or settlement on their child’s behalf.
Families who believe their child’s birth defects could have resulted from taking this migraine/seizure medication while pregnant should speak with a birth defect lawyer and consider joining the other families in filing a Depakote birth defect lawsuit.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
512 cases (2,048 trays) of Gordon Food Service (GFS) Sienna Bakery® Chocolate Decadent Brownies (GFS#226240) and Sienna Bakery® Chocolate Peanut Butter Brownies have been recalled by Dianne’s Fine Desserts due to a mislabeling and undeclared peanut, according to the FDA. Consumers who are allergic or
According to the FDA, Baxter Healthcare Corporation’s September 21, 2023 recall of its Novum IQ Syringe Pump is now identified as Class I, the most serious type, because use of the device has been found to put users at risk of serious injuries or death.
Publix Supermarkets, Inc., of Lakeland, Florida, has voluntarily recalled certain batches of private-label Egg Custard Pie sold between October 20, 2023 and November 16, 2023 because they may contain coconut, an allergen not listed on the product’s ingredient statement. Officials say the affected packages, which